World's Best Scientists 2026 revealed!
Yazdan Yazdanpanah

Yazdan Yazdanpanah

D-Index & Metrics

Medicine

D-Index
80
Citations
26581
World Ranking
17009
National Ranking
559

Yazdan Yazdanpanah publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yazdan Yazdanpanah sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 606 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yazdan Yazdanpanah D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yazdan Yazdanpanah sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yazdan Yazdanpanah is affiliated with Université Paris Cité in France and has a significant body of work primarily in the field of medicine, with a focus on infectious diseases. Their research spans across epidemiology, virology, general health professions, and molecular biology.

Their main fields of study include:

  • Medicine

Within the subfields, Yazdanpanah's work covers:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • General Health Professions
  • Molecular Biology

The scientist's research topics are diverse, with a strong emphasis on viral infections and public health concerns. These topics include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing
  • Poxvirus research and outbreaks

Yazdanpanah has published extensively in various scientific journals and venues, frequently contributing to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Médecine et Maladies Infectieuses
  • Médecine et Maladies Infectieuses Formation
  • Infectious Diseases Now

Among their recent papers are:

  • "Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients" (2020) published in Emerging Infectious Diseases
  • "Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study" (2020) published in The Lancet
  • "Clinical and virological data of the first cases of COVID-19 in Europe: a case series" (2020) published in The Lancet Infectious Diseases
  • "Type 1 interferons as a potential treatment against COVID-19" (2020) published in Antiviral Research
  • "Monkeypox" (2022) published in New England Journal of Medicine

Yazdanpanah collaborates frequently with other researchers, including:

  • François-Xavier Lescure
  • Nathan Peiffer-Smadja
  • Diane Descamps
  • France Mentré
  • Jade Ghosn

Best Publications

  • Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

    Nisreen M.A. Okba;Marcel A. Müller;Wentao Li;Chunyan Wang

  • Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study

    Marius Gilbert;Giulia Pullano;Francesco Pinotti;Eugenio Valdano

  • Clinical and virological data of the first cases of COVID-19 in Europe: a case series.

    Francois-Xavier Lescure;Francois-Xavier Lescure;Lila Bouadma;Lila Bouadma;Duc Nguyen;Marion Parisey

  • European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

    Jean-François Rahier;F Magro;C Abreu;A Armuzzi

  • Evidence of Sexual Transmission of Zika Virus

    Eric D'Ortenzio;Sophie Matheron;Yazdan Yazdanpanah;Xavier de Lamballerie

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Type 1 interferons as a potential treatment against COVID-19.

    Erwan Sallard;François Xavier Lescure;Yazdan Yazdanpanah

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.

    Lila Bouadma;Francois Xavier Lescure;Jean Christophe Lucet;Yazdan Yazdanpanah

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO Trial.

    Y. Yazdanpanah;C. Fagard;D. Descamps;A. M. Taburet

  • Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.

    Jürgen K Rockstroh;Edwin DeJesus;Jeffrey L Lennox;Yazdan Yazdanpanah

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis

    Nathalie Viget;Gwenola Vernier-Massouille;Dominique Salmon-Céron;Yazdan Yazdanpanah

  • Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

    Andrés Pizzorno;Blandine Padey;Thomas Julien;Sophie Trouillet-Assant;Sophie Trouillet-Assant

  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

    Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

  • WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus

    Holger J Schünemann;Suzanne R Hill;Meetali Kakad;Richard Bellamy

  • Review of human immunodeficiency virus type 1-related opportunisticinfections in sub-Saharan Africa

    C. B. Holmes;E. Losina;R. P. Walensky;Y. Yazdanpanah

Frequent Co-Authors

Jean-François Timsit
Jean-François Timsit Université Paris Cité
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1
Stanislas Pol
Stanislas Pol Université Paris Cité
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Patrice Cacoub
Patrice Cacoub Sorbonne University
Jacques Reynes
Jacques Reynes University of Montpellier
Fabrice Carrat
Fabrice Carrat Sorbonne University
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Dominique Larrey
Dominique Larrey University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a variety of educational journeys beyond the traditional MD route. Many students are now exploring flexible online degrees that cater to different interests, schedules, and long-term goals.

For those interested in advanced nursing, dnp programs without dissertation offer a way to earn a terminal degree in nursing without the pressure of completing a traditional dissertation, making it more accessible for working professionals.

If you’re looking to enter the workforce quickly, the 9 month lpn program provides a fast-track pathway to become a Licensed Practical Nurse in less than a year, all through online courses.

Mental health practitioners can take advantage of online msn pmhnp programs, which prepare nurses for specialization in psychiatric and mental health without lengthy campus commitments.

For those drawn to leadership and policy, healthcare administration degrees online deliver the skills needed to manage complex healthcare systems at an affordable cost.

Exploring these alternative online options can help you find a career path in healthcare that suits your lifestyle and professional goals.

Best Scientists Citing Yazdan Yazdanpanah

Trending Scientists

Recently Published Articles